Anti-Human ERBB3 & CD221 Recombinant Antibody

Name: Anti-Human ERBB3 & CD221 Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1370

YR1370

科研级 Istiratumab ( 艾司妥单抗 ), Anti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab

DATASHEET MSDS

Product Description

Alias	科研级 Istiratumab ( 艾司妥单抗 ), Anti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab
Catalog Number	YR1370
Molecular Name	Istiratumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa -[scFv]2
Formulation	PBS, pH7.5
Background	Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer.
CAS Number	1509928-04-4
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	ERBB3 & CD221[Homo sapiens]

Login